These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26152409)

  • 1. Chemical Compatibility and Safety of Imidacloprid/Flumethrin Collar (Seresto®) Concomitantly Used with Imidacloprid/Moxidectin (Advocate®, Advantage® Multi) and Emodepside/Praziquantel (Profender®) Spot-on Formulations.
    Krüdewagen EM; Remer C; Deuster K; Schunack B; Wolken S; Crafford D; Fourie J; Stanneck D
    Parasitol Res; 2015 Aug; 114 Suppl 1():S55-80. PubMed ID: 26152409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Speed of Kill, Repellent (anti-feeding) and Acaricidal Efficacy of an Imidacloprid/Flumethrin Collar (Seresto®) and a Fipronil/(S)-Methoprene/Eprinomectin/Praziquantel Spot-on (Broadline®) against Ixodes ricinus (Linné, 1758) on Cats.
    Fourie JJ; Horak IG; de Vos C; Deuster K; Schunack B
    Parasitol Res; 2015 Aug; 114 Suppl 1():S109-16. PubMed ID: 26152412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
    Krieger K; Heine J; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field comparison of tolerance of a collar containing 10.0% imidacloprid/4.5% flumethrin (Seresto) and a placebo collar placed on cats.
    Fink H; Wennogle S; Davis WL; Von Simson C; Lappin MR
    J Feline Med Surg; 2016 Dec; 18(12):1031-1033. PubMed ID: 26269454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and comparison of a flumethrin-imidacloprid collar and repeated monthly treatments of fipronil/(s)-methoprene to control flea, Ctenocephalides f. felis, infestations on cats for eight months.
    Dryden MW; Smith V; Davis WL; Settje T; Hostetler J
    Parasit Vectors; 2016 May; 9(1):287. PubMed ID: 27189592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Efficacy of an Imidacloprid/Flumethrin Collar (Seresto®) and an Oral Afoxolaner Chewable (NexGard®) against Tick (Dermacentor variabilis and Amblyomma americanum) Infestations on Dogs: a Randomised Controlled Trial.
    Ohmes CM; Hostetler J; Davis WL; Settje T; Everett WR
    Parasitol Res; 2015 Aug; 114 Suppl 1():S81-94. PubMed ID: 26152410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the prophylactic activity of a slow-release insecticide collar and a moxidectin spot-on formulation against Thelazia callipaeda infection in naturally exposed dogs in France.
    Lechat C; Siméon N; Pennant O; Desquilbet L; Chahory S; Le Sueur C; Guillot J
    Parasit Vectors; 2015 Feb; 8():93. PubMed ID: 25884443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus).
    Rohdich N; Zschiesche E; Wolf O; Loehlein W; Kirkova Z; Iliev P; Rapti D; Postoli R; Capári B; Farkas R; Roepke RKA
    Parasit Vectors; 2018 Nov; 11(1):589. PubMed ID: 30449275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the long-term efficacy and safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto®) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe.
    Stanneck D; Rass J; Radeloff I; Kruedewagen E; Le Sueur C; Hellmann K; Krieger K
    Parasit Vectors; 2012 Mar; 5():66. PubMed ID: 22463745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Efficacy of an Imidacloprid/Flumethrin Collar (Seresto®) and an Oral Fluralaner Chewable Tablet (Bravecto®) against Tick (Dermacentor variabilis and Amblyomma americanum) Infestations on Dogs: a Randomised Controlled Trial.
    Ohmes CM; Hostetler J; Davis WL; Settje T; McMinn A; Everett WR
    Parasitol Res; 2015 Aug; 114 Suppl 1():S95-108. PubMed ID: 26152411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
    Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
    Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of an imidacloprid 10 % / flumethrin 4.5 % collar (Seresto®, Bayer) for preventing the transmission of Cytauxzoon felis to domestic cats by Amblyomma americanum.
    Reichard MV; Thomas JE; Arther RG; Hostetler JA; Raetzel KL; Meinkoth JH; Little SE
    Parasitol Res; 2013 Aug; 112 Suppl 1():11-20. PubMed ID: 23760871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight-month repellency and efficacy of an imidacloprid/flumethrin (Seresto
    Smith VM; de Burgh SG; Jackson CM; Chambers MA; Page PC
    Aust Vet J; 2022 Mar; 100(3):83-89. PubMed ID: 34734411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory Evaluation of the Efficacy of 10 % Imidacloprid + 2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs.
    Bowman DD; Charles SD; Arther RG; Settje T
    Parasitol Res; 2015 Aug; 114 Suppl 1():S165-74. PubMed ID: 26152417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.
    Heine J; Krieger K; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S89-S96. PubMed ID: 16228281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.
    Otranto D; Colella V; Crescenzo G; Solari Basano F; Nazzari R; Capelli G; Petry G; Schaper R; Pollmeier M; Mallia E; Dantas-Torres F; Lia RP
    Vet Parasitol; 2016 Aug; 227():118-21. PubMed ID: 27523947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field evaluation of the efficacy and safety of emodepside/praziquantel spot-on solution against naturally acquired nematode and cestode infections in domestic cats.
    Altreuther G; Buch J; Charles SD; Davis WL; Krieger KJ; Radeloff I
    Parasitol Res; 2005 Oct; 97 Suppl 1():S58-S64. PubMed ID: 16228276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synergistic action of imidacloprid and flumethrin and their release kinetics from collars applied for ectoparasite control in dogs and cats.
    Stanneck D; Ebbinghaus-Kintscher U; Schoenhense E; Kruedewagen EM; Turberg A; Leisewitz A; Jiritschka W; Krieger KJ
    Parasit Vectors; 2012 Apr; 5():73. PubMed ID: 22498105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
    Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
    Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A flea and tick collar containing 10% imidacloprid and 4.5% flumethrin prevents flea transmission of Bartonella henselae in cats.
    Lappin MR; Davis WL; Hawley JR; Brewer M; Morris A; Stanneck D
    Parasit Vectors; 2013 Jan; 6():26. PubMed ID: 23351927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.